C-type natriuretic peptide and its role in bone growth
Author Information
Author(s): Agoston Hanga, Khan Sameena, James Claudine G, Gillespie J Ryan, Serra Rosa, Stanton Lee-Anne, Beier Frank
Primary Institution: University of Western Ontario
Hypothesis
C-type natriuretic peptide (CNP) regulates endochondral bone growth through p38 MAP kinase-dependent and independent pathways.
Conclusion
CNP enhances endochondral bone growth primarily by expanding the hypertrophic zone of the growth plate while delaying mineralization.
Supporting Evidence
- CNP treatment caused a 42% increase in longitudinal growth of tibiae.
- CNP significantly expanded the hypertrophic zone in the growth plate.
- Inhibition of p38 MAPK reversed the effects of CNP on bone growth.
- Microarray analyses identified numerous genes regulated by CNP in hypertrophic chondrocytes.
Takeaway
CNP helps bones grow by making certain cells bigger and keeping them around longer before they turn into bone.
Methodology
The study used an organ culture system of embryonic day 15.5 mouse tibiae to examine the effects of CNP on endochondral bone growth.
Limitations
The study does not distinguish between direct and indirect target genes of CNP due to the long-term exposure used.
Participant Demographics
Embryonic day 15.5 (E15.5) mouse tibiae were used for the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website